Lennox-Gastaut syndrome (LGS)

Active Ingredient: Rufinamide

Indication for Rufinamide

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Rufinamide is indicated as adjunctive therapy in the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 1 year of age and older.

For this indication, competent medicine agencies globally authorize below treatments:

400-3200 mg in 2 divided doses daily

Route of admnistration

Oral

Defined daily dose

400 - 3,200 mg

Dosage regimen

From 200 To 1,600 mg 2 time(s) per day every day

Loading dose

400 mg

Detailed description

Use in adults, adolescents and children 4 years of age or older of 30 kg or over

Patients >30 kg not receiving valproate

Treatment should be initiated at a daily dose of 400 mg. According to clinical response and tolerability, the dose may be increased by 400 mg/day increments, as frequently as every other day, up to a maximum recommended dose as indicated in the table below.

Weight range 30.0–50.0 kg 50.1–70.0 kg ≥70.1 kg
Maximum recommended dose1,800 mg/day 2,400 mg/day 3,200 mg/day

Doses of up to 4,000 mg/day (in the 30-50 kg range) or 4,800 mg/day (in the over 50 kg) have been studied in a limited number of patients.

Patients >30 kg also receiving valproate

Treatment should be initiated at a daily dose of 400 mg. According to clinical response and tolerability, the dose may be increased by 400 mg/day increments, as frequently as every other day, up to a maximum recommended dose as indicated in the table below.

Weight range 30.0–50.0 kg 50.1–70.0 kg ≥70.1 kg
Maximum recommended dose1,200 mg/day 1,600 mg/day 2,200 mg/day

Dosage considerations

Rufinamide should be administered with food.

Active ingredient

Rufinamide

Rufinamide is an anticonvulsant medication. Rufinamide modulates the activity of sodium channels, prolonging their inactive state.

Read more about Rufinamide

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.